English | Español

American Academy Of Neurology
Sam Jackson | Apr 25, 2023

Teriflunomide study shows promise in delaying first symptoms of MS using medication as an 'early intervention'
Sam Jackson | Apr 25, 2023

New drug shows promise in preventing migraines for patients unresponsive to other treatments: 'These results are exciting'

Press release submission | May 2, 2019

AMERICAN ACADEMY OF NEUROLOGY: Cannabis-based Medicine May Reduce Seizures for Children with Difficult-to-Treat Epilepsy
Robert Hadley | May 16, 2017

Immunosuppressive drug cladribine may slow progression of MS

Ruth de Jauregui | May 7, 2017

Data from multiple sclerosis medication study shows promise
Robert Hadley | May 3, 2017

Clinical trial results offer hope for multiple sclerosis sufferers
Amanda Rupp | May 22, 2016

New ALS research announced at annual conference
Amanda Rupp | Apr 21, 2016

ALS Association announces new research fellowships

Trending
Patient Daily | Oct 9, 2025

Medfluence Advisors Marketing Expert: 'The conversations leading into AAO-HNSF are shaping how ENT practices approach growth and engagement'
+ Technology/Innovation
Patient Daily News Service | Oct 9, 2025

Babylon Health collapse raises questions about AI claims across industries
Patient Daily | Oct 9, 2025

AI takes center stage at ASCENT ENT conference, reshaping marketing and operations
+ Regulatory
Patient Daily | Oct 14, 2025

Mackinac Center raises concerns over federal 340B drug pricing program’s market impact